ArticleRheumatology international2026
Clinical spectrum and diagnostic outcomes of patients with suspected inflammatory rheumatic disease in the emergency department: a retrospective study.
Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Little is known about patients presenting to the emergency department (ED) with rheumatological complaints. We aimed to characterize rheumatological patients in the ED and analyze the role of the rheumatologist in their management. This retrospective single-center cohort study analyzed 340 patients presenting to the emergency department (ED) between 2019 and 2023 with a suspected new inflammatory rheumatic disease (IRD). Clinical and process data were evaluated. In addition, multivariable logistic regression and a neural network model were employed to identify factors that are predictive of a subsequent diagnosis of IRD. Arthritis and arthralgia (55%) were the most common symptoms among patients with susIRD, but a wide spectrum of symptoms were observed, including myalgias (23%) and B-Symptoms (20%). Most patients presented as urgencies rather than true emergencies. Symptom duration prior to ED presentation was longer than 7 days in 69% of patients. However, 63% required in-patient management. Overall,y 62% of patients with susIRD were eventually diagnosed with an IRD. Immunosuppressive or anti-inflammatory medication was started in 92% of these. The most common diagnoses were polymyalgia rheumatica (7.9%), reactive arthritis/para infectious arthritis (7.3%) and rheumatoid arthritis (6.3%). Infections (10%) constituted the most common non-rheumatological diagnosis. A logistic regression model and a neural network could predict the presence of an IRD with accuracies of 74% and 60% respectively. Polyarthritis/Polyarthralgia and swollen joints were the strongest positive predictors for IRD. When consulting rheumatologists suspected an IRD, this impression was confirmed by the final diagnosis in 87% of patients. Integrating the rheumatologist's impression into the models increased the accuracy of the logistic regression to 85% and the neural network to 77%. Most rheumatological patients present to the ED with arthritis/arthralgias and urgent rather than life-threatening conditions. Whilst our models could predict IRD with moderate accuracy, consulting rheumatologists demonstrated high diagnostic precision, indicating the need for rheumatological expertise in the ED.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.